The Effects of Oxytocin Treatment on Social Touch

The Effects of Oxytocin on Social Touch: an fNIRS-based Study

The main aim of the study is to investigate the modulatory effects of oxytocin (24IU) administration on the affective processing of touch manipulated differently in gentle caress-like stroke vs. social massage with a moderate pressure.

Study Overview

• Status: Completed
• Conditions: Healthy
• Intervention / Treatment: Drug: Intranasal oxytocin; Drug: Oral oxytocin; Drug: Placebo

Detailed Description

A randomized double-blind placebo-controlled mixed experimental design with three arms (intranasal oxytocin administration vs. oral oxytocin administration vs. placebo administration, each with 60 subjects) will be employed in the current study. 35 minutes after treatment subjects will be applied two different types of pleasant touch (social massage vs. caress-like stroking) to their calf. After each applied touch stimulation session, the subjects will be asked to rate their subjective experience of the touch including the perceived pleasantness, arousal, intensity and payment. The neural basis of touch processing will be measured via simultaneously acquired fNIRS together with skin conductance responses and the electrocardiogram recording. Blood samples will be taken before and after the treatment as well as after each run session to measure plasma oxytocin levels to explore the associations with primary outcome measure (the behavioral and neural measures of touch processing). Mixed-measure analysis of variance (ANOVA) with treatment as between-subject factor and condition as within-subject factor will be used to investigate oxytocin effects on social touch processing.

To control potential confounding effects across groups, before the experiment all participants will be asked to complete a range of Chinese versions of validated questionnaires on personality, traits, attitude towards interpersonal touch and sensitivity to reward: Autism Spectrum Quotient (ASQ), Beck Depression Inventory II (BDI), State-Trait Anxiety Inventory (STAI), the Cheek and Buss Shyness Scale (CBSS), the Adult Attachment Scale (AAS), the Childhood Trauma Questionnaire (CTQ), social touch questionnaire (STQ), Sensitivity to Punishment and Sensitivity to Reward Questionnaire (SPSRQ), Sensory Over-Responsivity (SensOR) Scales and the Interpersonal Reactivity Index (C-IRI). And associations between questionnaire scores (especially the ASQ and STQ scores) with primary outcome measure will be explored to investigate modulatory effects of autistic traits. Additionally, to control for potential confounding effects of treatment on mood across the experiment, the Positive and Negative Affect Schedule (PANAS) will be administered immediately before and 30 minutes after the treatment. Participants will also complete the PANAS after each type of touch condition to further measure the modulatory effects of stroking touch and massage on mood.

• Study Type: Interventional
• Enrollment (Actual): 180
• Phase: Not Applicable

Contacts and Locations

Study Locations

• China
  • Sichuan
    • Chengdu, Sichuan, China, 611731
      • University of Electronic Science and Technology of China(UESTC)

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 30 years (Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Healthy subjects without any past or present psychiatric or neurological disorders and without any current psychotherapeutic medication.

Exclusion Criteria:

• Any history of brain injury, psychiatric/physical illness, alcohol/substance abuse, or other major health concern.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Basic Science
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Triple

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Intranasal oxytocin; Participants will be randomly assigned to the administration of oxytocin intranasal spray (24 IU).	Drug: Intranasal oxytocin; Each subject will be assigned to administration of oxytocin intranasal spray (24 IU).; Other Names: Oxytocin intranasal spray
Experimental: Oral oxytocin; Participants will be randomly assigned to the administration of oxytocin lingual spray (24 IU).	Drug: Oral oxytocin; Each subject will be assigned to administration of oxytocin lingual spray (24 IU).; Other Names: Oxytocin lingual spray
Placebo Comparator: Placebo; Participants will be randomly assigned to the administration of placebo.	Drug: Placebo; An identical amount of intranasal administration of placebo (identical ingredients except the peptide - i.e. glycerine and sodium chloride) will be assigned to each subject.; Other Names: PLC

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Neural index: fNIRS based measures of touch processing	fNIRS-based indices of neural processing of social touch after the oxytocin and placebo administration in response to each experimental condition.	35-90 minutes after treatment administration
Behavioral index: ratings of the pleasantness, arousal, intensity and payment for the applied social touch	Ratings of perceived pleasantness, arousal, intensity and the willing to pay for the applied caress-like touch and massage after the oxytocin and placebo administration.	50-90 minutes after treatment administration

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Plasma oxytocin concentration	Basal and altered blood oxytocin concentrations for different treatment groups before and 30 minutes after the administration as well as after each touch condition.	Basal concentration before treatment and altered level during 30-90 minutes after treatment administration
Electrophysiological index: skin conductance responses (SCR)	SCR amplitudes during touch processing to further investigate oxytocin effects on each experimental condition compared with the placebo.	35-90 minutes after treatment administration
Electrophysiological index: heart rate variability (HRV)	HRV reflecting the variability in consecutive heartbeats calculated from electrocardiography during touch processing to further investigate oxytocin effects on each experimental condition compared with the placebo.	35-90 minutes after treatment administration
Questionnaire scores of autistic traits	The Autism Spectrum Quotient (ASQ) scores (0~50, higher scores mean higher autistic trait) to investigate modulatory effects of autistic traits.	Before the experiment
Gender difference in the neural and behavioral index	Gender difference in the neural and behavioral response during the touch processing for different treatment groups.	35-90 minutes after treatment administration

Collaborators and Investigators

• Sponsor: University of Electronic Science and Technology of China
• Investigators: Study Chair: Qin Li, Dr., University of Electronic Science and Technology of China

Study record dates

Study Major Dates

• Study Start (Actual): September 1, 2021
• Primary Completion (Actual): March 1, 2022
• Study Completion (Actual): May 25, 2022

Study Registration Dates

• First Submitted: February 20, 2022
• First Submitted That Met QC Criteria: March 1, 2022
• First Posted (Actual): March 4, 2022

Study Record Updates

• Last Update Posted (Estimate): May 11, 2023
• Last Update Submitted That Met QC Criteria: May 10, 2023
• Last Verified: May 1, 2023

More Information

Terms related to this study

• Keywords: Oxytocin; fNIRS; Social touch
• Additional Relevant MeSH Terms: Physiological Effects of Drugs; Reproductive Control Agents; Oxytocics; Oxytocin
• Other Study ID Numbers: UESTC-neuSCAN-79

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No